Abstract
The American Joint Committee on Cancer (AJCC) staging system for melanoma has recently been revised and published. The previous staging system had not been substantially modified since the late 1980s. In a series of papers, the staging system for melanoma was critically analyzed, and many shortcomings were identified. Many well-established prognostic factors were not used in the staging system. This assessment has led to a substantially modified staging system for cutaneous melanoma in 2001 that is a considerable improvement over past staging systems, albeit more complex. The following modifications are the most important: 1) The primary determinant of tumor (T) staging is tumor thickness as measured in millimeters. The Clark level of invasion is now used only for defining T1 (£1 mm) melanomas; 2) The cutpoints for tumor thickness are less than or equal to 1 mm, 1 to 2 mm, 2 to 4 mm, and greater than 4 mm; 3) Ulceration has been added in describing the primary tumor; 4) Local recurrence, satellite disease, and in-transit metastases have similar prognosis and are now all classified together as regional stage III disease; 5) Size of lymph node as prognostic factor has been eliminated and replaced with the number of positive nodes; 6) The presence of an elevated serum lactic dehyrogenase level is used in the metastasis (M) category. This revised staging system more precisely defines prognosis and will improve the stratification of patients in future clinical trials.
Similar content being viewed by others
References and Recommended Reading
Bearhs OH, Myers MH: Manual for Staging of Cancer: American Joint Committee on Cancer. Philadelphia: JB Lippincott; 1983.
American Joint Committee on Cancer: Manual for Staging of Cancer, edn 4. Philadelphia: JB Lippincott; 1992.
Buzaid AC, Ross MI, Balch CM, et al.: Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997, 15:1039–1051. The first article to critically analyze the shortcomings of the AJCC staging system that led to the revised staging system.
Ross M: Modifying the criteria of the American Joint Commission on Cancer staging system in melanoma. Curr Opin Oncol 1998, 10:153–161. Detailed analysis of the old AJCC staging system with suggestions for modifications.
Balch CM, Buzaid AC, Soong SJ, et al.: Final version of the AJCC staging system for cutaneous melanoma. J Clin Oncol 2001, in press. Final version of the new AJCC system. Important for all medical oncologists, dermatologists, surgeons, pathologists, and tumor registrars.
Balch CM, Buzaid AC, Atkins, M, et al.: A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000, 88:1484–1491.
Balch CM, Buzaid AC, Soong SJ, et al.: Prognostic factor analysis of 17,600 melanoma patients: validation of the AJCC melanoma staging system. J Clin Oncol 2001, in press. Important companion paper that describes in detail the prognostic factors used to generate the new staging system.
Clark WH Jr: Classification of malignant melanoma in man correlated with histogeneis and biologic behavior. In Advances in Biology of the Skin: The Pigmentary System. Edited by Montanga W, Hu F. London: Pergamon Press; 1967:621.
Breslow A: Thickness, cross-sectional areas and depth of the invasion on the prognosis of cutaneous melanoma. Ann Surg 1970, 172:902–908.
Balch CM, Wilkerson, JA, Murad TM, et al.: The prognostic significance of ulceration of cutaneous melanoma. Cancer 1980, 45:3012–3017.
Elenitsas R, Schuchter LM: The role of the pathologist in the diagnosis of melanoma. Curr Opin Oncol 1998, 10:162–169.
Coit D: Prognostic factors in patients with melanoma metastatic to regional lymph nodes. Surg Oncol Clin N Am 1992, 1:281–295.
Ross MI, Reintgen D, Balch CM: Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993, 9:219–223. Very detailed paper on the role of sentinel lymph node mapping.
Reintgen DS, Conrad AJ: Detection of occult melanoma cells in sentinel lymph nodes and blood. Semin Oncol 1997, 24:S11-S15.
Sirott M, Bajorin D, Wong G, et al.: Prognostic factors in patients with metastatic malignant melanoma: a multivariate analysis. Cancer 1993, 72:3091–3098.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schuchter, L.M. Review of the 2001 AJCC staging system for cutaneous malignant melanoma. Curr Oncol Rep 3, 332–337 (2001). https://doi.org/10.1007/s11912-001-0086-4
Issue Date:
DOI: https://doi.org/10.1007/s11912-001-0086-4